To scale up protein production in order to compare and advance antibody therapeutics against COVID-19 around the world through our interanional consortium.

Key facts

Disease
COVID-19
Funder
Emergent Ventures Fast Grants
Principal Investigator
Dr. Erica Ollmann Saphire
Research Location
United States of America
Lead Research Institution
La Jolla Institute for Immunology
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract